Honest pros, cons, and verdict on this ai healthcare tool
✅ FDA 510(k) clearance for AISight Dx with PCCP enables regulatory-compliant AI diagnostics
Starting Price
Enterprise
Free Tier
No
Category
AI Healthcare
Skill Level
No Code
AI-powered digital pathology platform providing FDA-cleared diagnostic tools, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies.
PathAI builds AI-powered pathology software that helps laboratories and pharmaceutical companies analyze tissue samples with greater accuracy and efficiency. The company's flagship product, AISight, is a cloud-native digital pathology platform that serves as a central hub for case management, slide image management, and AI-powered diagnostic applications across histopathology workflows.
PathAI received FDA 510(k) clearance for AISight Dx in 2022, and in 2025 obtained additional FDA clearance with a Predetermined Change Control Plan (PCCP) that allows specific future AI enhancements without new regulatory submissions. This regulatory approach positions PathAI ahead of most competitors in the digital pathology space.
Clinical decision support AI that assists healthcare professionals with differential diagnosis, medical knowledge search, and evidence-based clinical reasoning.
Starting at Freemium
Learn more →AI-powered medical imaging platform that accelerates diagnosis and treatment of critical conditions
Starting at Paid
Learn more →AI clinical insights platform that reviews 100% of patient chart data to recommend diagnoses, generate draft documentation, and surface missed conditions at the point of care.
Starting at Paid
Learn more →PathAI delivers on its promises as a ai healthcare tool. While it has some limitations, the benefits outweigh the drawbacks for most users in its target market.
AI-powered digital pathology platform providing FDA-cleared diagnostic tools, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies.
Yes, PathAI is good for ai healthcare work. Users particularly appreciate fda 510(k) clearance for aisight dx with pccp enables regulatory-compliant ai diagnostics. However, keep in mind enterprise-only pricing excludes small independent pathology practices.
PathAI starts at Enterprise. Check their pricing page for the most current rates and features included in each plan.
PathAI is best for Enterprise hospital pathology departments transitioning from glass slides to AI-assisted digital workflows and Pharmaceutical companies standardizing biomarker analysis across multi-site oncology clinical trials. It's particularly useful for ai healthcare professionals who need health monitoring.
Popular PathAI alternatives include Glass AI, Viz.ai, Regard. Each has different strengths, so compare features and pricing to find the best fit.
Last verified March 2026